Portfolio (Quarterly)
Guide ↗
Stonepine Capital Management, LLC
· CIK 0001440771| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | QNRX | QUOIN PHARMACEUTICALS LTD | Healthcare | 53,460.0 | $353K | 0.14% | -25K | -31.6% | $6.60 | -24.5% |
| 62 | ESTA | ESTABLISHMENT LABS HLDGS INC | Healthcare | 6,000.0 | $341K | 0.14% | NEW | — | $56.78 | +27.5% |
| 63 | — | UPSTREAM BIO INC | — | 35,000.0 | $315K | 0.13% | NEW | — | $9.00 | — |
| 64 | — | OPUS GENETICS INC | — | 68,688.0 | $313K | 0.12% | NEW | — | $4.55 | — |
| 65 | ARVN | ARVINAS INC | Healthcare | 27,500.0 | $292K | 0.12% | NEW | — | $10.60 | -15.6% |
| 66 | PLRX | PLIANT THERAPEUTICS INC | Healthcare | 224,650.0 | $283K | 0.11% | -5K | -2.4% | $1.26 | -2.4% |
| 67 | JANX | JANUX THERAPEUTICS INC | Healthcare | 20,000.0 | $278K | 0.11% | — | — | $13.90 | +3.7% |
| 68 | OABI | OMNIAB INC | Healthcare | 164,045.0 | $258K | 0.10% | -537K | -76.6% | $1.57 | +60.8% |
| 69 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 40,030.0 | $232K | 0.09% | NEW | — | $5.80 | +7.2% |
| 70 | CGEN | COMPUGEN LTD | Healthcare | 104,300.0 | $222K | 0.09% | -201K | -65.8% | $2.13 | +24.9% |
| 71 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 100,000.0 | $195K | 0.08% | NEW | — | $1.95 | -6.9% |
| 72 | — | SAB BIOTHERAPEUTICS INC | — | 50,000.0 | $192K | 0.08% | NEW | — | $3.83 | — |
| 73 | SIBN | SI BONE INC | Healthcare | 14,964.0 | $189K | 0.08% | NEW | — | $12.63 | +15.1% |
| 74 | — | EDESA BIOTECH INC | — | 30,000.0 | $157K | 0.06% | -658K | -95.6% | $5.23 | — |
| 75 | CNSP | CNS PHARMACEUTICALS INC | Healthcare | 61,000.0 | $146K | 0.06% | +12K | +24.9% | $2.39 | +124.7% |
| 76 | PCSA | PROCESSA PHARMACEUTICALS INC | Healthcare | 55,000.0 | $139K | 0.06% | +43K | +346.3% | $2.52 | +0.2% |
| 77 | CABA | CABALETTA BIO INC | Healthcare | 50,000.0 | $134K | 0.05% | -121K | -70.8% | $2.69 | +36.6% |
| 78 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 20,400.0 | $118K | 0.05% | NEW | — | $5.77 | -9.4% |
| 79 | ELDN | ELEDON PHARMACEUTICALS INC | Healthcare | 35,000.0 | $108K | 0.04% | -858K | -96.1% | $3.08 | +26.0% |
| 80 | OVID | OVID THERAPEUTICS INC | Healthcare | 40,000.0 | $89K | 0.04% | -62K | -60.9% | $2.22 | +9.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%